Rosiglitazone elevates sensitization of drug-resistant oral epidermoid carcinoma cells to vincristine by G2/M-phase arrest, independent of PPAR-γ pathway | |
Wang H.-Y.; Zhang Y.; Zhou Y.; Lu Y.-Y.; Wang W.-F.; Xin M.; Guo X.-L. | |
刊名 | Biomedicine and Pharmacotherapy
![]() |
2016 | |
卷号 | 83页码:349-361 |
关键词 | Cell cycle Cell proliferation and apoptosis Drug resistance reversal Oral epidermoid carcinoma PTEN/PI3K/AKT Rosiglitazone Vincristine |
DOI | 10.1016/j.biopha.2016.06.047 |
URL标识 | 查看原文 |
内容类型 | 期刊论文 |
URI标识 | http://www.corc.org.cn/handle/1471x/4712978 |
专题 | 山东大学 |
作者单位 | Department of Pharmacology, Key Laboratory of Chemical Biology , School of Pharmaceutical Sciences, Shandong Unive |
推荐引用方式 GB/T 7714 | Wang H.-Y.,Zhang Y.,Zhou Y.,et al. Rosiglitazone elevates sensitization of drug-resistant oral epidermoid carcinoma cells to vincristine by G2/M-phase arrest, independent of PPAR-γ pathway[J]. Biomedicine and Pharmacotherapy,2016,83:349-361. |
APA | Wang H.-Y..,Zhang Y..,Zhou Y..,Lu Y.-Y..,Wang W.-F..,...&Guo X.-L..(2016).Rosiglitazone elevates sensitization of drug-resistant oral epidermoid carcinoma cells to vincristine by G2/M-phase arrest, independent of PPAR-γ pathway.Biomedicine and Pharmacotherapy,83,349-361. |
MLA | Wang H.-Y.,et al."Rosiglitazone elevates sensitization of drug-resistant oral epidermoid carcinoma cells to vincristine by G2/M-phase arrest, independent of PPAR-γ pathway".Biomedicine and Pharmacotherapy 83(2016):349-361. |
个性服务 |
查看访问统计 |
相关权益政策 |
暂无数据 |
收藏/分享 |
除非特别说明,本系统中所有内容都受版权保护,并保留所有权利。
修改评论